65,437 trials
Knee Arthroplasty, Total
Primary: Percentage of Patients Presenting With Pain in the Back of the Knee 6 Hours After Surgery — 21.7; 45.8 percentage of patients reporting pain
Cervical Spinal Cord Injury
Primary: Change in Electromyogram (EMG) — -.0031 mV
Atrial Fibrillation · Familial Atrial Fibrillation · Arrythmia, Cardiac
Primary: Proportion of Days Covered — 1.0; 0.9 Proportion of days covered — p=0.22
Irritability Associated With Autism Spectrum Disorder
Primary: Number of Participants With Treatment-emergent Adverse Events (TEAEs) Graded By Severity, Serious TEAEs and Trial Discontinuation Due to TEAEs — 23; 24; 15; 19…
Overdose
Primary: Absorption of Acetaminophen as Indicated by Area Under the Curve — 3566; 3335 mcg*min/mL
Influenza Immunization
Primary: Geometric Mean Titers (GMTs) Against Influenza Vaccine Antibodies at Day 29 — 1946; 982; 1975; 604 titer
Peripheral Artery Disease
Primary: Six-minute Walk Distance — 17.01; 3.46 meters — p=0.7586
Gonorrhea
Primary: Number of Participants With Culture-Confirmed Bacterial Eradication of Neisseria Gonorrhoeae (NG) From the Urogenital Site at the Test-Of-Cure (TOC) Visit (Day 4 to 8)…
Critically Ill · Post Intensive Care Syndrome
Primary: Change in Regional Hemoglobin Oxygen Saturation — 75.65; 77.01; 73.83; 77.09 percent of oxygenation — p=<0.0001
Colitis, Ulcerative · Crohn Disease
Primary: Percentage of Participants With One or More Treatment Intensifications for CD Participants — 30.7; 42.1 percentage of participants — p==0.13202
Pneumococcal Disease
Primary: Percentage of Participants With Solicited Injection-site Adverse Events (AEs) — 32.9; 39.1 Percentage of participants
Mechanical Ventilation Complication · Diaphragm Injury
Primary: Mitochondrial Respiration — 3.5; 2.9; 31.1; 27.1 pmol/s/mg wwt
Asthma, COPD
Primary: Effect of FP-025 Versus Placebo on the Allergen (HDM)-Induced Late Asthmatic Response (LAR) in Subjects With Clinically Stable, Mild Allergic Asthma and Blood…
Degenerative Joint Disease of Hip
Primary: Implant Survivorship — 133; 2 Participants
Cervical Degenerative Disc Disorder
Primary: Number of Participants With Clinical Composite Success, Parent IDE Study + Post Approval Study (PAS) — 117; 40 Participants